umlaut_journal_tocs 0.0.1
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- checksums.yaml +7 -0
- data/MIT-LICENSE +20 -0
- data/Rakefile +37 -0
- data/app/item_decorators/umlaut_journal_tocs_decorator.rb +50 -0
- data/app/service_adaptors/journal_tocs_adapter.rb +51 -0
- data/app/views/umlaut_journal_tocs/_bento_item.html.erb +80 -0
- data/app/views/umlaut_journal_tocs/_resolve_section.html.erb +10 -0
- data/config/locales/en.yml +5 -0
- data/config/routes.rb +2 -0
- data/lib/tasks/umlaut_journal_tocs_tasks.rake +4 -0
- data/lib/umlaut_journal_tocs.rb +26 -0
- data/lib/umlaut_journal_tocs/engine.rb +18 -0
- data/lib/umlaut_journal_tocs/version.rb +3 -0
- data/test/controller_test.rb +36 -0
- data/test/dummy/README.rdoc +28 -0
- data/test/dummy/Rakefile +6 -0
- data/test/dummy/app/assets/javascripts/application.js +17 -0
- data/test/dummy/app/assets/stylesheets/application.css +19 -0
- data/test/dummy/app/controllers/application_controller.rb +5 -0
- data/test/dummy/app/controllers/umlaut_controller.rb +136 -0
- data/test/dummy/app/helpers/application_helper.rb +2 -0
- data/test/dummy/app/views/layouts/application.html.erb +14 -0
- data/test/dummy/bin/bundle +3 -0
- data/test/dummy/bin/rails +4 -0
- data/test/dummy/bin/rake +4 -0
- data/test/dummy/bin/setup +29 -0
- data/test/dummy/config.ru +4 -0
- data/test/dummy/config/application.rb +26 -0
- data/test/dummy/config/boot.rb +5 -0
- data/test/dummy/config/database.yml +60 -0
- data/test/dummy/config/environment.rb +5 -0
- data/test/dummy/config/environments/development.rb +45 -0
- data/test/dummy/config/environments/production.rb +83 -0
- data/test/dummy/config/environments/test.rb +42 -0
- data/test/dummy/config/initializers/assets.rb +11 -0
- data/test/dummy/config/initializers/backtrace_silencers.rb +7 -0
- data/test/dummy/config/initializers/cookies_serializer.rb +3 -0
- data/test/dummy/config/initializers/filter_parameter_logging.rb +4 -0
- data/test/dummy/config/initializers/inflections.rb +16 -0
- data/test/dummy/config/initializers/mime_types.rb +4 -0
- data/test/dummy/config/initializers/session_store.rb +3 -0
- data/test/dummy/config/initializers/umlaut_journal_tocs.rb +20 -0
- data/test/dummy/config/initializers/wrap_parameters.rb +14 -0
- data/test/dummy/config/locales/en.yml +23 -0
- data/test/dummy/config/routes.rb +57 -0
- data/test/dummy/config/secrets.yml +22 -0
- data/test/dummy/config/umlaut_services.yml +23 -0
- data/test/dummy/db/migrate/20150901192508_umlaut_init.umlaut.rb +106 -0
- data/test/dummy/db/migrate/20150901192509_umlaut_add_service_response_index.umlaut.rb +10 -0
- data/test/dummy/db/schema.rb +118 -0
- data/test/dummy/public/404.html +67 -0
- data/test/dummy/public/422.html +67 -0
- data/test/dummy/public/500.html +66 -0
- data/test/dummy/public/favicon.ico +0 -0
- data/test/journal_tocs_adapter_test.rb +93 -0
- data/test/support/vcr_filter.rb +45 -0
- data/test/test_helper.rb +39 -0
- data/test/vcr_cassettes/generates_no_response.yml +49 -0
- data/test/vcr_cassettes/generates_response.yml +952 -0
- data/test/vcr_cassettes/gets_results.yml +804 -0
- data/test/vcr_cassettes/registers_proper_error.yml +40 -0
- metadata +200 -0
@@ -0,0 +1,67 @@
|
|
1
|
+
<!DOCTYPE html>
|
2
|
+
<html>
|
3
|
+
<head>
|
4
|
+
<title>The page you were looking for doesn't exist (404)</title>
|
5
|
+
<meta name="viewport" content="width=device-width,initial-scale=1">
|
6
|
+
<style>
|
7
|
+
body {
|
8
|
+
background-color: #EFEFEF;
|
9
|
+
color: #2E2F30;
|
10
|
+
text-align: center;
|
11
|
+
font-family: arial, sans-serif;
|
12
|
+
margin: 0;
|
13
|
+
}
|
14
|
+
|
15
|
+
div.dialog {
|
16
|
+
width: 95%;
|
17
|
+
max-width: 33em;
|
18
|
+
margin: 4em auto 0;
|
19
|
+
}
|
20
|
+
|
21
|
+
div.dialog > div {
|
22
|
+
border: 1px solid #CCC;
|
23
|
+
border-right-color: #999;
|
24
|
+
border-left-color: #999;
|
25
|
+
border-bottom-color: #BBB;
|
26
|
+
border-top: #B00100 solid 4px;
|
27
|
+
border-top-left-radius: 9px;
|
28
|
+
border-top-right-radius: 9px;
|
29
|
+
background-color: white;
|
30
|
+
padding: 7px 12% 0;
|
31
|
+
box-shadow: 0 3px 8px rgba(50, 50, 50, 0.17);
|
32
|
+
}
|
33
|
+
|
34
|
+
h1 {
|
35
|
+
font-size: 100%;
|
36
|
+
color: #730E15;
|
37
|
+
line-height: 1.5em;
|
38
|
+
}
|
39
|
+
|
40
|
+
div.dialog > p {
|
41
|
+
margin: 0 0 1em;
|
42
|
+
padding: 1em;
|
43
|
+
background-color: #F7F7F7;
|
44
|
+
border: 1px solid #CCC;
|
45
|
+
border-right-color: #999;
|
46
|
+
border-left-color: #999;
|
47
|
+
border-bottom-color: #999;
|
48
|
+
border-bottom-left-radius: 4px;
|
49
|
+
border-bottom-right-radius: 4px;
|
50
|
+
border-top-color: #DADADA;
|
51
|
+
color: #666;
|
52
|
+
box-shadow: 0 3px 8px rgba(50, 50, 50, 0.17);
|
53
|
+
}
|
54
|
+
</style>
|
55
|
+
</head>
|
56
|
+
|
57
|
+
<body>
|
58
|
+
<!-- This file lives in public/404.html -->
|
59
|
+
<div class="dialog">
|
60
|
+
<div>
|
61
|
+
<h1>The page you were looking for doesn't exist.</h1>
|
62
|
+
<p>You may have mistyped the address or the page may have moved.</p>
|
63
|
+
</div>
|
64
|
+
<p>If you are the application owner check the logs for more information.</p>
|
65
|
+
</div>
|
66
|
+
</body>
|
67
|
+
</html>
|
@@ -0,0 +1,67 @@
|
|
1
|
+
<!DOCTYPE html>
|
2
|
+
<html>
|
3
|
+
<head>
|
4
|
+
<title>The change you wanted was rejected (422)</title>
|
5
|
+
<meta name="viewport" content="width=device-width,initial-scale=1">
|
6
|
+
<style>
|
7
|
+
body {
|
8
|
+
background-color: #EFEFEF;
|
9
|
+
color: #2E2F30;
|
10
|
+
text-align: center;
|
11
|
+
font-family: arial, sans-serif;
|
12
|
+
margin: 0;
|
13
|
+
}
|
14
|
+
|
15
|
+
div.dialog {
|
16
|
+
width: 95%;
|
17
|
+
max-width: 33em;
|
18
|
+
margin: 4em auto 0;
|
19
|
+
}
|
20
|
+
|
21
|
+
div.dialog > div {
|
22
|
+
border: 1px solid #CCC;
|
23
|
+
border-right-color: #999;
|
24
|
+
border-left-color: #999;
|
25
|
+
border-bottom-color: #BBB;
|
26
|
+
border-top: #B00100 solid 4px;
|
27
|
+
border-top-left-radius: 9px;
|
28
|
+
border-top-right-radius: 9px;
|
29
|
+
background-color: white;
|
30
|
+
padding: 7px 12% 0;
|
31
|
+
box-shadow: 0 3px 8px rgba(50, 50, 50, 0.17);
|
32
|
+
}
|
33
|
+
|
34
|
+
h1 {
|
35
|
+
font-size: 100%;
|
36
|
+
color: #730E15;
|
37
|
+
line-height: 1.5em;
|
38
|
+
}
|
39
|
+
|
40
|
+
div.dialog > p {
|
41
|
+
margin: 0 0 1em;
|
42
|
+
padding: 1em;
|
43
|
+
background-color: #F7F7F7;
|
44
|
+
border: 1px solid #CCC;
|
45
|
+
border-right-color: #999;
|
46
|
+
border-left-color: #999;
|
47
|
+
border-bottom-color: #999;
|
48
|
+
border-bottom-left-radius: 4px;
|
49
|
+
border-bottom-right-radius: 4px;
|
50
|
+
border-top-color: #DADADA;
|
51
|
+
color: #666;
|
52
|
+
box-shadow: 0 3px 8px rgba(50, 50, 50, 0.17);
|
53
|
+
}
|
54
|
+
</style>
|
55
|
+
</head>
|
56
|
+
|
57
|
+
<body>
|
58
|
+
<!-- This file lives in public/422.html -->
|
59
|
+
<div class="dialog">
|
60
|
+
<div>
|
61
|
+
<h1>The change you wanted was rejected.</h1>
|
62
|
+
<p>Maybe you tried to change something you didn't have access to.</p>
|
63
|
+
</div>
|
64
|
+
<p>If you are the application owner check the logs for more information.</p>
|
65
|
+
</div>
|
66
|
+
</body>
|
67
|
+
</html>
|
@@ -0,0 +1,66 @@
|
|
1
|
+
<!DOCTYPE html>
|
2
|
+
<html>
|
3
|
+
<head>
|
4
|
+
<title>We're sorry, but something went wrong (500)</title>
|
5
|
+
<meta name="viewport" content="width=device-width,initial-scale=1">
|
6
|
+
<style>
|
7
|
+
body {
|
8
|
+
background-color: #EFEFEF;
|
9
|
+
color: #2E2F30;
|
10
|
+
text-align: center;
|
11
|
+
font-family: arial, sans-serif;
|
12
|
+
margin: 0;
|
13
|
+
}
|
14
|
+
|
15
|
+
div.dialog {
|
16
|
+
width: 95%;
|
17
|
+
max-width: 33em;
|
18
|
+
margin: 4em auto 0;
|
19
|
+
}
|
20
|
+
|
21
|
+
div.dialog > div {
|
22
|
+
border: 1px solid #CCC;
|
23
|
+
border-right-color: #999;
|
24
|
+
border-left-color: #999;
|
25
|
+
border-bottom-color: #BBB;
|
26
|
+
border-top: #B00100 solid 4px;
|
27
|
+
border-top-left-radius: 9px;
|
28
|
+
border-top-right-radius: 9px;
|
29
|
+
background-color: white;
|
30
|
+
padding: 7px 12% 0;
|
31
|
+
box-shadow: 0 3px 8px rgba(50, 50, 50, 0.17);
|
32
|
+
}
|
33
|
+
|
34
|
+
h1 {
|
35
|
+
font-size: 100%;
|
36
|
+
color: #730E15;
|
37
|
+
line-height: 1.5em;
|
38
|
+
}
|
39
|
+
|
40
|
+
div.dialog > p {
|
41
|
+
margin: 0 0 1em;
|
42
|
+
padding: 1em;
|
43
|
+
background-color: #F7F7F7;
|
44
|
+
border: 1px solid #CCC;
|
45
|
+
border-right-color: #999;
|
46
|
+
border-left-color: #999;
|
47
|
+
border-bottom-color: #999;
|
48
|
+
border-bottom-left-radius: 4px;
|
49
|
+
border-bottom-right-radius: 4px;
|
50
|
+
border-top-color: #DADADA;
|
51
|
+
color: #666;
|
52
|
+
box-shadow: 0 3px 8px rgba(50, 50, 50, 0.17);
|
53
|
+
}
|
54
|
+
</style>
|
55
|
+
</head>
|
56
|
+
|
57
|
+
<body>
|
58
|
+
<!-- This file lives in public/500.html -->
|
59
|
+
<div class="dialog">
|
60
|
+
<div>
|
61
|
+
<h1>We're sorry, but something went wrong.</h1>
|
62
|
+
</div>
|
63
|
+
<p>If you are the application owner check the logs for more information.</p>
|
64
|
+
</div>
|
65
|
+
</body>
|
66
|
+
</html>
|
File without changes
|
@@ -0,0 +1,93 @@
|
|
1
|
+
require 'test_helper'
|
2
|
+
|
3
|
+
class JournalTocsAdapterTest < ActiveSupport::TestCase
|
4
|
+
extend TestWithCassette
|
5
|
+
|
6
|
+
before do
|
7
|
+
@service_config = {
|
8
|
+
"type" => "JournalTocsAdapter",
|
9
|
+
"priority" => 1
|
10
|
+
}
|
11
|
+
@service_config_list = {'default' => {
|
12
|
+
"services" => {
|
13
|
+
"journal_tocs" => @service_config
|
14
|
+
}
|
15
|
+
}
|
16
|
+
}
|
17
|
+
|
18
|
+
@service = JournalTocsAdapter.new(@service_config.merge("service_id" => "journal_tocs"))
|
19
|
+
end
|
20
|
+
|
21
|
+
describe "with no ISSN" do
|
22
|
+
test "does nothing" do
|
23
|
+
umlaut_request = fake_umlaut_request("/resolve?jtitle=Journal+Of+Something&genre=journal")
|
24
|
+
|
25
|
+
@service.handle(umlaut_request)
|
26
|
+
|
27
|
+
assert_dispatched umlaut_request, "journal_tocs"
|
28
|
+
assert_service_responses umlaut_request, 'journal_tocs', :number => 0
|
29
|
+
end
|
30
|
+
end
|
31
|
+
|
32
|
+
describe "article-level citation" do
|
33
|
+
test "does nothing" do
|
34
|
+
@umlaut_request = fake_umlaut_request("/resolve?jtitle=JAMA&genre=article&issn=1538-3598&volume=1&issue=1&spage=1")
|
35
|
+
@service.handle(@umlaut_request)
|
36
|
+
|
37
|
+
assert_dispatched @umlaut_request, "journal_tocs"
|
38
|
+
response = assert_service_responses @umlaut_request, 'journal_tocs', :number => 0
|
39
|
+
end
|
40
|
+
end
|
41
|
+
|
42
|
+
describe "with ISSN that works" do
|
43
|
+
before do
|
44
|
+
@umlaut_request = fake_umlaut_request("/resolve?au=JAMA&genre=journal&issn=1538-3598")
|
45
|
+
end
|
46
|
+
|
47
|
+
test_with_cassette "generates response" do
|
48
|
+
@service.handle(@umlaut_request)
|
49
|
+
|
50
|
+
assert_dispatched @umlaut_request, "journal_tocs"
|
51
|
+
response = assert_service_responses @umlaut_request, 'journal_tocs', :number => 1
|
52
|
+
|
53
|
+
# Can we de-serialize?
|
54
|
+
bento_results = BentoSearch::Results.load_json(response.service_data)
|
55
|
+
|
56
|
+
assert_kind_of BentoSearch::Results, bento_results
|
57
|
+
assert bento_results.count > 0
|
58
|
+
bento_results.each do |result|
|
59
|
+
assert_kind_of BentoSearch::ResultItem, result
|
60
|
+
end
|
61
|
+
end
|
62
|
+
end
|
63
|
+
|
64
|
+
describe "with ISSN with no JournalTocs results" do
|
65
|
+
before do
|
66
|
+
@umlaut_request = fake_umlaut_request("/resolve?au=JAMA&genre=journal&issn=12345678")
|
67
|
+
end
|
68
|
+
|
69
|
+
test_with_cassette("generates no response") do
|
70
|
+
@service.handle(@umlaut_request)
|
71
|
+
|
72
|
+
assert_dispatched @umlaut_request, "journal_tocs"
|
73
|
+
assert_service_responses @umlaut_request, 'journal_tocs', :number => 0
|
74
|
+
end
|
75
|
+
end
|
76
|
+
|
77
|
+
describe "with bad email" do
|
78
|
+
before do
|
79
|
+
config = @service_config.merge("service_id" => "journal_tocs",
|
80
|
+
"bento_search_engine" => "bad_email_journal_tocs")
|
81
|
+
@service = JournalTocsAdapter.new(config)
|
82
|
+
|
83
|
+
@umlaut_request = fake_umlaut_request("/resolve?au=JAMA&genre=journal&issn=12345678")
|
84
|
+
end
|
85
|
+
test_with_cassette "registers proper error" do
|
86
|
+
@service.handle(@umlaut_request)
|
87
|
+
|
88
|
+
assert_dispatched @umlaut_request, "journal_tocs", "failed_temporary"
|
89
|
+
assert_service_responses @umlaut_request, 'journal_tocs', :number => 0
|
90
|
+
end
|
91
|
+
end
|
92
|
+
|
93
|
+
end
|
@@ -0,0 +1,45 @@
|
|
1
|
+
require 'vcr'
|
2
|
+
|
3
|
+
# Convenience for using VCR's filter_sensitive_data according to our common
|
4
|
+
# pattern.
|
5
|
+
#
|
6
|
+
# For a sensitive piece of information, set in your shell environment variable eg:
|
7
|
+
#
|
8
|
+
# BD_FINDITEM_PATRON="patron_barcode"
|
9
|
+
#
|
10
|
+
# Then call in a test:
|
11
|
+
# VCRFilter.sensitive_data! :bd_finditem_patron
|
12
|
+
#
|
13
|
+
# In the tests, when you need to use the piece of data somewhere, use
|
14
|
+
# VCRFilter[:bd_library_symbol]
|
15
|
+
#
|
16
|
+
# eg
|
17
|
+
# BorrowDirect::FindItem.new(VCRFilter[:bd_finditem_patron])
|
18
|
+
#
|
19
|
+
# Optional but recommended, use VCR cassette tags...
|
20
|
+
# VCRFilter.sensitive_data!, :bd_finditem_patron, :bd_finditem_tests
|
21
|
+
# #...
|
22
|
+
# describe "BD finditem items", :vcr => {:tag => :bd_finditem_tests}
|
23
|
+
#
|
24
|
+
# When recording a new cassette, the value from ENV will be used in interactions
|
25
|
+
# with remote service, but won't be saved in your on disk cassettes -- it will
|
26
|
+
# be saved as eg DUMMY_BD_FINDITEM_PATRON instead.
|
27
|
+
#
|
28
|
+
# When running from recorded cassettes, you don't need to have the ENV defined, but
|
29
|
+
# when (re-)recording a cassette, you of course do.
|
30
|
+
module VCRFilter
|
31
|
+
@@data = {}
|
32
|
+
def self.[](key) ; @@data[key.to_s.downcase] ; end
|
33
|
+
def self.[]=(key, value) ; @@data[key.to_s.downcase] = value ; end
|
34
|
+
|
35
|
+
def self.sensitive_data!(key, vcr_tag = nil)
|
36
|
+
env_key = key.to_s.upcase
|
37
|
+
dummy_value = "DUMMY_#{env_key}"
|
38
|
+
|
39
|
+
self[key] = (ENV[env_key] || dummy_value)
|
40
|
+
|
41
|
+
VCR.configure do |c|
|
42
|
+
c.filter_sensitive_data( dummy_value, vcr_tag ) { self[key] }
|
43
|
+
end
|
44
|
+
end
|
45
|
+
end
|
data/test/test_helper.rb
ADDED
@@ -0,0 +1,39 @@
|
|
1
|
+
# Configure Rails Environment
|
2
|
+
ENV["RAILS_ENV"] = "test"
|
3
|
+
|
4
|
+
require File.expand_path("../../test/dummy/config/environment.rb", __FILE__)
|
5
|
+
ActiveRecord::Migrator.migrations_paths = [File.expand_path("../../test/dummy/db/migrate", __FILE__)]
|
6
|
+
require "rails/test_help"
|
7
|
+
|
8
|
+
require 'minitest-spec-rails'
|
9
|
+
|
10
|
+
require 'umlaut'
|
11
|
+
require 'umlaut/test_help'
|
12
|
+
include Umlaut::TestHelp
|
13
|
+
|
14
|
+
# Filter out Minitest backtrace while allowing backtrace from other libraries
|
15
|
+
# to be shown.
|
16
|
+
Minitest.backtrace_filter = Minitest::BacktraceFilter.new
|
17
|
+
|
18
|
+
# Load support files
|
19
|
+
Dir["#{File.dirname(__FILE__)}/support/**/*.rb"].each do |f|
|
20
|
+
require f
|
21
|
+
end
|
22
|
+
|
23
|
+
|
24
|
+
|
25
|
+
# Load fixtures from the engine
|
26
|
+
if ActiveSupport::TestCase.respond_to?(:fixture_path=)
|
27
|
+
ActiveSupport::TestCase.fixture_path = File.expand_path("../fixtures", __FILE__)
|
28
|
+
ActiveSupport::TestCase.fixtures :all
|
29
|
+
end
|
30
|
+
|
31
|
+
if defined?(VCR)
|
32
|
+
VCR.configure do |c|
|
33
|
+
c.cassette_library_dir = 'test/vcr_cassettes'
|
34
|
+
c.hook_into :webmock # or :fakeweb
|
35
|
+
end
|
36
|
+
end
|
37
|
+
|
38
|
+
VCRFilter.sensitive_data! :journal_tocs_email
|
39
|
+
|
@@ -0,0 +1,49 @@
|
|
1
|
+
---
|
2
|
+
http_interactions:
|
3
|
+
- request:
|
4
|
+
method: get
|
5
|
+
uri: http://www.journaltocs.ac.uk/api/journals/12345678?output=articles&user=DUMMY_JOURNAL_TOCS_EMAIL
|
6
|
+
body:
|
7
|
+
encoding: UTF-8
|
8
|
+
string: ''
|
9
|
+
headers:
|
10
|
+
User-Agent:
|
11
|
+
- HTTPClient/1.0 (2.6.0.1, ruby 2.2.2 (2015-04-13))
|
12
|
+
Accept:
|
13
|
+
- "*/*"
|
14
|
+
Date:
|
15
|
+
- Thu, 03 Sep 2015 20:09:21 GMT
|
16
|
+
response:
|
17
|
+
status:
|
18
|
+
code: 200
|
19
|
+
message: OK
|
20
|
+
headers:
|
21
|
+
Date:
|
22
|
+
- Thu, 03 Sep 2015 20:09:21 GMT
|
23
|
+
Server:
|
24
|
+
- Apache
|
25
|
+
X-Powered-By:
|
26
|
+
- PHP/5.3.3
|
27
|
+
Content-Length:
|
28
|
+
- '1192'
|
29
|
+
Content-Type:
|
30
|
+
- application/xml; charset=utf-8
|
31
|
+
body:
|
32
|
+
encoding: UTF-8
|
33
|
+
string: "<?xml version=\"1.0\" encoding=\"utf-8\"?>\n<rdf:RDF xmlns:rdf=\"http://www.w3.org/1999/02/22-rdf-syntax-ns#\"\r\n
|
34
|
+
\ xmlns=\"http://purl.org/rss/1.0/\"\r\n xmlns:mn=\"http://usefulinc.com/rss/manifest/\"\r\n
|
35
|
+
\ xmlns:dc=\"http://purl.org/dc/elements/1.1/\">\n\n <channel rdf:about=\"http://www.journaltocs.hw.ac.uk/api/journals\">\r\n
|
36
|
+
\ <title>JournalTOCs API - Found 0 journals for: 12345678 (0 articles)</title>\r\n
|
37
|
+
\ <link>http://www.journaltocs.ac.uk/api/journals/12345678</link>\r\n <description><![CDATA[Your
|
38
|
+
query: 12345678 has returned 0 articles. Table of contents is currently unavailable
|
39
|
+
for this journal. Please report to S.Chumbe@hw.ac.uk]]></description>\r\n
|
40
|
+
\ <dc:publisher>JournalTOCs API</dc:publisher>\r\n <dc:creator>JOURNALTOCS
|
41
|
+
API PROJECT</dc:creator>\r\n\t\t<dc:coverage>0</dc:coverage>\r\n <image
|
42
|
+
rdf:resource=\"http://www.journaltocs.ac.uk/images/jtocslogo.gif\" />\r\n
|
43
|
+
\ <items>\r\n <rdf:Seq>\r\n </rdf:Seq>\r\n </items>\r\n </channel>\r\n
|
44
|
+
\ \r\n\t\r\n <rdf:Description rdf:ID=\"manifest\">\r\n <mn:channels>\r\n
|
45
|
+
\ <rdf:Seq>\r\n <rdf:li rdf:resource=\"http://www.journaltocs.hw.ac.uk/api/journals\"
|
46
|
+
/>\r\n </rdf:Seq>\r\n </mn:channels>\r\n </rdf:Description>\r\n\r\n</rdf:RDF>"
|
47
|
+
http_version:
|
48
|
+
recorded_at: Thu, 03 Sep 2015 20:09:21 GMT
|
49
|
+
recorded_with: VCR 2.9.3
|
@@ -0,0 +1,952 @@
|
|
1
|
+
---
|
2
|
+
http_interactions:
|
3
|
+
- request:
|
4
|
+
method: get
|
5
|
+
uri: http://www.journaltocs.ac.uk/api/journals/15383598?output=articles&user=DUMMY_JOURNAL_TOCS_EMAIL
|
6
|
+
body:
|
7
|
+
encoding: UTF-8
|
8
|
+
string: ''
|
9
|
+
headers:
|
10
|
+
User-Agent:
|
11
|
+
- HTTPClient/1.0 (2.6.0.1, ruby 2.2.2 (2015-04-13))
|
12
|
+
Accept:
|
13
|
+
- "*/*"
|
14
|
+
Date:
|
15
|
+
- Thu, 03 Sep 2015 20:09:19 GMT
|
16
|
+
response:
|
17
|
+
status:
|
18
|
+
code: 200
|
19
|
+
message: OK
|
20
|
+
headers:
|
21
|
+
Date:
|
22
|
+
- Thu, 03 Sep 2015 20:09:20 GMT
|
23
|
+
Server:
|
24
|
+
- Apache
|
25
|
+
X-Powered-By:
|
26
|
+
- PHP/5.3.3
|
27
|
+
Transfer-Encoding:
|
28
|
+
- chunked
|
29
|
+
Content-Type:
|
30
|
+
- application/xml; charset=utf-8
|
31
|
+
body:
|
32
|
+
encoding: UTF-8
|
33
|
+
string: "<?xml version=\"1.0\" encoding=\"UTF-8\"?>\n<rdf:RDF xmlns:rdf=\"http://www.w3.org/1999/02/22-rdf-syntax-ns#\"
|
34
|
+
\r\n xmlns:prism=\"http://prismstandard.org/namespaces/1.2/basic/\"
|
35
|
+
\r\n\t\t\t\t xmlns:dc=\"http://purl.org/dc/elements/1.1/\" \r\n\t\t\t\t xmlns:mn=\"http://usefulinc.com/rss/manifest/\"\r\n\t\t\t\t
|
36
|
+
xmlns:content=\"http://purl.org/rss/1.0/modules/content/\" \r\n\t\t\t\t xmlns=\"http://purl.org/rss/1.0/\">\n\n
|
37
|
+
\ <channel rdf:about=\"http://www.journaltocs.hw.ac.uk/api/journals\">\r\n
|
38
|
+
\ <title>JournalTOCs API - JAMA The Journal of the American Medical Association
|
39
|
+
(38 articles)</title>\r\n <link>http://www.journaltocs.ac.uk/api/journals/15383598</link>\r\n
|
40
|
+
\ <description><![CDATA[Your query: 15383598 has returned 38 articles. They
|
41
|
+
are listed in alphabetical order per journal (maximum number of returned items
|
42
|
+
is 3000).]]></description>\r\n <dc:publisher>JournalTOCs API</dc:publisher>\r\n
|
43
|
+
\ <dc:creator>JOURNALTOCS API PROJECT</dc:creator>\r\n\t\t<dc:coverage>1</dc:coverage>\r\n
|
44
|
+
\ <image rdf:resource=\"http://www.journaltocs.ac.uk/images/jtocslogo.gif\"
|
45
|
+
/>\r\n <items>\r\n <rdf:Seq><rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429716\"
|
46
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429719\"
|
47
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429717\"
|
48
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429702\"
|
49
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429693\"
|
50
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429712\"
|
51
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429698\"
|
52
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429725\"
|
53
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429724\"
|
54
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429688\"
|
55
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429709\"
|
56
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429699\"
|
57
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429700\"
|
58
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429695\"
|
59
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429691\"
|
60
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2424669\"
|
61
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429711\"
|
62
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429710\"
|
63
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429694\"
|
64
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429706\"
|
65
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429705\"
|
66
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429707\"
|
67
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429690\"
|
68
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429689\"
|
69
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429713\"
|
70
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429714\"
|
71
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429715\"
|
72
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429696\"
|
73
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429697\"
|
74
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429692\"
|
75
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429703\"
|
76
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429704\"
|
77
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429701\"
|
78
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2338495\"
|
79
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429723\"
|
80
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2319350\"
|
81
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2338303\"
|
82
|
+
/>\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429718\"
|
83
|
+
/>\n\r\n </rdf:Seq>\r\n </items>\r\n </channel>\r\n <item rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429716\">\n<title>Childhood
|
84
|
+
Obesity</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429716</link>\r\n<description><span
|
85
|
+
class=\"paragraphSection\"></span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429716</dc:identifier>\r\n<dc:creator>Thompson
|
86
|
+
AE.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
|
87
|
+
The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
88
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
89
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429716\"><b>Childhood
|
90
|
+
Obesity</b></A><br />Thompson AE. <br /><i>JAMA The Journal of the American
|
91
|
+
Medical Association, Vol. , No. (2015) pp. - </i><br /><span class=\"paragraphSection\"></span></p>]]></content:encoded>\r\n</item>\n<item
|
92
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429719\">\n<title>JAMA</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429719</link>\r\n<description><br>\nArticle
|
93
|
+
URL: http://jama.jamanetwork.com/article.aspx?articleID=2429719<br>\nCitation:
|
94
|
+
\ (2015) <br>\nPublication Date: Tue, 25 Aug 2015 00:00:00 GMT<br>\nJournal:
|
95
|
+
JAMA The Journal of the American Medical Association</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429719</dc:identifier>\r\n<dc:publisher>American
|
96
|
+
Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
|
97
|
+
of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
98
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
99
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429719\"><b>JAMA</b></A><br
|
100
|
+
/> <br /><i>JAMA The Journal of the American Medical Association, Vol. , No.
|
101
|
+
\ (2015) pp. - </i><br />\nArticle URL: http://jama.jamanetwork.com/article.aspx?articleID=2429719\nCitation:
|
102
|
+
\ (2015) \nPublication Date: Tue, 25 Aug 2015 00:00:00 GMT\nJournal: JAMA
|
103
|
+
The Journal of the American Medical Association</p>]]></content:encoded>\r\n</item>\n<item
|
104
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429717\">\n<title>Knowing</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429717</link>\r\n<description><span
|
105
|
+
class=\"paragraphSection\">Streaks of blue above the treetopsand brightening
|
106
|
+
white cloudsbeneath the heavier still windless graysin this tilt to longer
|
107
|
+
light already under waytogether with a shift of knowingstirred as endless
|
108
|
+
colorin this window patch of sky.And in my lungs a space of knowing named
|
109
|
+
at last,which like the changed sky, forever changing,subtle as the light of
|
110
|
+
so much more to know remaining.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429717</dc:identifier>\r\n<dc:creator>Halberstadt
|
111
|
+
C.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
|
112
|
+
The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
113
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
114
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429717\"><b>Knowing</b></A><br
|
115
|
+
/>Halberstadt C. <br /><i>JAMA The Journal of the American Medical Association,
|
116
|
+
Vol. , No. (2015) pp. - </i><br /><span class=\"paragraphSection\">Streaks
|
117
|
+
of blue above the treetopsand brightening white cloudsbeneath the heavier
|
118
|
+
still windless graysin this tilt to longer light already under waytogether
|
119
|
+
with a shift of knowingstirred as endless colorin this window patch of sky.And
|
120
|
+
in my lungs a space of knowing named at last,which like the changed sky, forever
|
121
|
+
changing,subtle as the light of so much more to know remaining.</span></p>]]></content:encoded>\r\n</item>\n<item
|
122
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429702\">\n<title>The
|
123
|
+
House: Its Unique Problems in Hygiene</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429702</link>\r\n<description><span
|
124
|
+
class=\"paragraphSection\">A house erected in accord with modern science
|
125
|
+
and the builder’s art must satisfy a few apparently simple needs. These
|
126
|
+
have been cleverly summarized in the following words: protection from the
|
127
|
+
elements, from cold and heat, from rain and snow and damp, from intruders
|
128
|
+
who might interfere with the family safety or possessions; water at hand;
|
129
|
+
some way of getting rid of waste; space for the family, for all their occupations
|
130
|
+
and belongings; room for a guest: these were sought by even the cave dwellers.
|
131
|
+
And we have not passed beyond these simple needs. Our enemies are of a different
|
132
|
+
kind, but the daily paper shows that we must pay for safety locks; and while
|
133
|
+
wild animals no longer prowl about, we find it almost impossible to keep out
|
134
|
+
rats and mice and harmful insects. The “house” fly is now called
|
135
|
+
a “typhoid” fly, and not permitted even as a casual visitor. To
|
136
|
+
all these needs we have added what the cave man did not seek for, since his
|
137
|
+
life was largely out of doors. We must have air and sun within doors. Doctors
|
138
|
+
are now talking about house diseases. Tuberculosis is one of these, and the
|
139
|
+
fight against it must be made, in part, just here. It is for sun and air that
|
140
|
+
we have to pay large rents in town; and it is partly to secure these in our
|
141
|
+
large dwellings that tenement-house commissions exist, to protect those who
|
142
|
+
cannot protect themselves. Then, too, there must be protection against fire,
|
143
|
+
not only by the fire department but also in the house itself. Modern nerves,
|
144
|
+
moreover, demand quiet. We may want our own phonograph, but we do not care
|
145
|
+
to hear our neighbor’s, and walls and floors must be built to keep out
|
146
|
+
sounds. We call these simple needs. They would seem to be human rights; but
|
147
|
+
even now, in this twentieth century, how many houses rank 100 per cent. in
|
148
|
+
all these: in warmth and coolness at proper seasons; perfect dryness, ventilation
|
149
|
+
and lighting; safety from fire and intruders; and room for each member of
|
150
|
+
the family to be by himself, and to keep an open door to guests' Yet,
|
151
|
+
we cannot be as well or as happy or as useful as we should, until these are
|
152
|
+
achieved.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429702</dc:identifier>\r\n<dc:publisher>American
|
153
|
+
Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
|
154
|
+
of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
155
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
156
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429702\"><b>The
|
157
|
+
House: Its Unique Problems in Hygiene</b></A><br /> <br /><i>JAMA The Journal
|
158
|
+
of the American Medical Association, Vol. , No. (2015) pp. - </i><br /><span
|
159
|
+
class=\"paragraphSection\">A house erected in accord with modern science
|
160
|
+
and the builder’s art must satisfy a few apparently simple needs. These
|
161
|
+
have been cleverly summarized in the following words: protection from the
|
162
|
+
elements, from cold and heat, from rain and snow and damp, from intruders
|
163
|
+
who might interfere with the family safety or possessions; water at hand;
|
164
|
+
some way of getting rid of waste; space for the family, for all their occupations
|
165
|
+
and belongings; room for a guest: these were sought by even the cave dwellers.
|
166
|
+
And we have not passed beyond these simple needs. Our enemies are of a different
|
167
|
+
kind, but the daily paper shows that we must pay for safety locks; and while
|
168
|
+
wild animals no longer prowl about, we find it almost impossible to keep out
|
169
|
+
rats and mice and harmful insects. The “house” fly is now called
|
170
|
+
a “typhoid” fly, and not permitted even as a casual visitor. To
|
171
|
+
all these needs we have added what the cave man did not seek for, since his
|
172
|
+
life was largely out of doors. We must have air and sun within doors. Doctors
|
173
|
+
are now talking about house diseases. Tuberculosis is one of these, and the
|
174
|
+
fight against it must be made, in part, just here. It is for sun and air that
|
175
|
+
we have to pay large rents in town; and it is partly to secure these in our
|
176
|
+
large dwellings that tenement-house commissions exist, to protect those who
|
177
|
+
cannot protect themselves. Then, too, there must be protection against fire,
|
178
|
+
not only by the fire department but also in the house itself. Modern nerves,
|
179
|
+
moreover, demand quiet. We may want our own phonograph, but we do not care
|
180
|
+
to hear our neighbor’s, and walls and floors must be built to keep out
|
181
|
+
sounds. We call these simple needs. They would seem to be human rights; but
|
182
|
+
even now, in this twentieth century, how many houses rank 100 per cent. in
|
183
|
+
all these: in warmth and coolness at proper seasons; perfect dryness, ventilation
|
184
|
+
and lighting; safety from fire and intruders; and room for each member of
|
185
|
+
the family to be by himself, and to keep an open door to guests' Yet,
|
186
|
+
we cannot be as well or as happy or as useful as we should, until these are
|
187
|
+
achieved.</span></p>]]></content:encoded>\r\n</item>\n<item rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429693\">\n<title>Next-Generation
|
188
|
+
Sequencing to Detect Minimal Residual Disease in AML</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429693</link>\r\n<description><span
|
189
|
+
class=\"paragraphSection\">Acute myeloid leukemia (AML) represents a heterogeneous
|
190
|
+
disease, both with respect to molecular pathogenesis and clinical outcome.
|
191
|
+
Although dose-intensive chemotherapy and allogeneic stem cell transplantation
|
192
|
+
have improved outcomes in AML, there remains significant heterogeneity in
|
193
|
+
clinical outcome such that approximately 20% of patients are cured with existing
|
194
|
+
therapies, 20% have therapy-refractory disease from the time of diagnosis,
|
195
|
+
and 50% relapse and die from refractory disease after an initial response
|
196
|
+
to leukemia therapy. The challenge is how to best determine prognosis and
|
197
|
+
identify which patients will have a substantive chance of cure, and which
|
198
|
+
patients will likely relapse or present with refractory disease. Current standard
|
199
|
+
of care uses clinical, cytogenetic, and molecular factors for risk stratification;
|
200
|
+
however, there remains a pressing need for better approaches to prognostication
|
201
|
+
in AML.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429693</dc:identifier>\r\n<dc:creator>Pastore
|
202
|
+
F</dc:creator>\n<dc:creator>Levine RL.</dc:creator>\n<dc:publisher>American
|
203
|
+
Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
|
204
|
+
of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
205
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
206
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429693\"><b>Next-Generation
|
207
|
+
Sequencing to Detect Minimal Residual Disease in AML</b></A><br />Pastore
|
208
|
+
F Levine RL.<br /><i>JAMA The Journal of the American Medical Association,
|
209
|
+
Vol. , No. (2015) pp. - </i><br /><span class=\"paragraphSection\">Acute
|
210
|
+
myeloid leukemia (AML) represents a heterogeneous disease, both with respect
|
211
|
+
to molecular pathogenesis and clinical outcome. Although dose-intensive chemotherapy
|
212
|
+
and allogeneic stem cell transplantation have improved outcomes in AML, there
|
213
|
+
remains significant heterogeneity in clinical outcome such that approximately
|
214
|
+
20% of patients are cured with existing therapies, 20% have therapy-refractory
|
215
|
+
disease from the time of diagnosis, and 50% relapse and die from refractory
|
216
|
+
disease after an initial response to leukemia therapy. The challenge is how
|
217
|
+
to best determine prognosis and identify which patients will have a substantive
|
218
|
+
chance of cure, and which patients will likely relapse or present with refractory
|
219
|
+
disease. Current standard of care uses clinical, cytogenetic, and molecular
|
220
|
+
factors for risk stratification; however, there remains a pressing need for
|
221
|
+
better approaches to prognostication in AML.</span></p>]]></content:encoded>\r\n</item>\n<item
|
222
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429712\">\n<title>Activity
|
223
|
+
Intervention vs Health Education in Sedentary Older Adults</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429712</link>\r\n<description><span
|
224
|
+
class=\"paragraphSection\">This randomized trial assessed the effects of
|
225
|
+
a 24-month physical activity program on cognitive function, mild cognitive
|
226
|
+
impairment, and dementia compared with a health education program in sedentary
|
227
|
+
adults aged 70 to 89 years.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429712</dc:identifier>\r\n<dc:creator>Sink
|
228
|
+
KM</dc:creator>\n<dc:creator>Espeland MA</dc:creator>\n<dc:creator>Castro
|
229
|
+
CM</dc:creator>\n<dc:creator>et al.</dc:creator>\n<dc:publisher>American Medical
|
230
|
+
Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal of the
|
231
|
+
American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
232
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
233
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429712\"><b>Activity
|
234
|
+
Intervention vs Health Education in Sedentary Older Adults</b></A><br />Sink
|
235
|
+
KM Espeland MA, Castro CM, et al.<br /><i>JAMA The Journal of the American
|
236
|
+
Medical Association, Vol. , No. (2015) pp. - </i><br /><span class=\"paragraphSection\">This
|
237
|
+
randomized trial assessed the effects of a 24-month physical activity program
|
238
|
+
on cognitive function, mild cognitive impairment, and dementia compared with
|
239
|
+
a health education program in sedentary adults aged 70 to 89 years.</span></p>]]></content:encoded>\r\n</item>\n<item
|
240
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429698\">\n<title>Recommendations
|
241
|
+
to Improve Cardiac Arrest Survival</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429698</link>\r\n<description><span
|
242
|
+
class=\"paragraphSection\">About 600 000 people in the United States
|
243
|
+
experience cardiac arrest each year, and the National Academy of Medicine
|
244
|
+
(NAM) recently released a report titled “Strategies to Improve Cardiac
|
245
|
+
Arrest Survival: A Time to Act” that details cardiac arrest outcomes
|
246
|
+
in the United States and provides recommendations for increasing cardiac arrest
|
247
|
+
survival rates (<a href=\"http://bit.ly/1HSyLOQ\">http://bit.ly/1HSyLOQ</a>).
|
248
|
+
The NAM convened a committee of experts to conduct the study, sponsored by
|
249
|
+
the American Heart Association, American Red Cross, American College of Cardiology,
|
250
|
+
Centers for Disease Control and Prevention, National Institutes of Health,
|
251
|
+
and US Department of Veterans Affairs. According to the report, current survival
|
252
|
+
rates are less than 6% for individuals who experience cardiac arrest outside
|
253
|
+
of the hospital and less than 24% for patients who experience cardiac arrest
|
254
|
+
while hospitalized.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429698</dc:identifier>\r\n<dc:creator>Jacob
|
255
|
+
JA.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
|
256
|
+
The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
257
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
258
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429698\"><b>Recommendations
|
259
|
+
to Improve Cardiac Arrest Survival</b></A><br />Jacob JA. <br /><i>JAMA The
|
260
|
+
Journal of the American Medical Association, Vol. , No. (2015) pp. - </i><br
|
261
|
+
/><span class=\"paragraphSection\">About 600 000 people in the
|
262
|
+
United States experience cardiac arrest each year, and the National Academy
|
263
|
+
of Medicine (NAM) recently released a report titled “Strategies to Improve
|
264
|
+
Cardiac Arrest Survival: A Time to Act” that details cardiac arrest
|
265
|
+
outcomes in the United States and provides recommendations for increasing
|
266
|
+
cardiac arrest survival rates (<a href=\"http://bit.ly/1HSyLOQ\">http://bit.ly/1HSyLOQ</a>).
|
267
|
+
The NAM convened a committee of experts to conduct the study, sponsored by
|
268
|
+
the American Heart Association, American Red Cross, American College of Cardiology,
|
269
|
+
Centers for Disease Control and Prevention, National Institutes of Health,
|
270
|
+
and US Department of Veterans Affairs. According to the report, current survival
|
271
|
+
rates are less than 6% for individuals who experience cardiac arrest outside
|
272
|
+
of the hospital and less than 24% for patients who experience cardiac arrest
|
273
|
+
while hospitalized.</span></p>]]></content:encoded>\r\n</item>\n<item
|
274
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429725\">\n<title>Health
|
275
|
+
Advice Needed to Cut US Sodium Intake</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429725</link>\r\n<description><span
|
276
|
+
class=\"paragraphSection\">About half of nearly 200 000 US adults
|
277
|
+
reported in a recent survey that they’re watching their salt intake
|
278
|
+
or reducing it, but only 1 in 5 said a health professional advised them to
|
279
|
+
cut back. The data are from the 2013 Behavioral Risk Factor Surveillance System
|
280
|
+
telephone survey, which for the first time has provided state-level estimates
|
281
|
+
of sodium intake among the general population.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429725</dc:identifier>\r\n<dc:publisher>American
|
282
|
+
Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
|
283
|
+
of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
284
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
285
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429725\"><b>Health
|
286
|
+
Advice Needed to Cut US Sodium Intake</b></A><br /> <br /><i>JAMA The Journal
|
287
|
+
of the American Medical Association, Vol. , No. (2015) pp. - </i><br /><span
|
288
|
+
class=\"paragraphSection\">About half of nearly 200 000 US adults
|
289
|
+
reported in a recent survey that they’re watching their salt intake
|
290
|
+
or reducing it, but only 1 in 5 said a health professional advised them to
|
291
|
+
cut back. The data are from the 2013 Behavioral Risk Factor Surveillance System
|
292
|
+
telephone survey, which for the first time has provided state-level estimates
|
293
|
+
of sodium intake among the general population.</span></p>]]></content:encoded>\r\n</item>\n<item
|
294
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429724\">\n<title>Rapid
|
295
|
+
US Response to Ebola Threat</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429724</link>\r\n<description><span
|
296
|
+
class=\"paragraphSection\">More than 10 000 US residents were monitored
|
297
|
+
for potential Ebola virus exposure from November 2014 to March 2015 after
|
298
|
+
the CDC issued guidance on preventing transmission of the virus in the United
|
299
|
+
States, according to a recent report.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429724</dc:identifier>\r\n<dc:publisher>American
|
300
|
+
Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
|
301
|
+
of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
302
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
303
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429724\"><b>Rapid
|
304
|
+
US Response to Ebola Threat</b></A><br /> <br /><i>JAMA The Journal of the
|
305
|
+
American Medical Association, Vol. , No. (2015) pp. - </i><br /><span
|
306
|
+
class=\"paragraphSection\">More than 10 000 US residents were monitored
|
307
|
+
for potential Ebola virus exposure from November 2014 to March 2015 after
|
308
|
+
the CDC issued guidance on preventing transmission of the virus in the United
|
309
|
+
States, according to a recent report.</span></p>]]></content:encoded>\r\n</item>\n<item
|
310
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429688\">\n<title>Mahabalipooram</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429688</link>\r\n<description><span
|
311
|
+
class=\"paragraphSection\">The extraordinary life of Edward Lear (1812-1888)
|
312
|
+
seems to continue in spirit across space and time from Victorian England to
|
313
|
+
the present-day world, conveyed in his captivating works. It may be amusing
|
314
|
+
to consider that the same person who concocted the whimsical poem “The
|
315
|
+
Owl and the Pussy-cat” also gave art lessons to the Queen. Ornithological
|
316
|
+
illustrations were included in his early oeuvre, with his later work featuring
|
317
|
+
landscapes emanating the allure of faraway lands. </span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429688</dc:identifier>\r\n<dc:creator>Smith
|
318
|
+
JM.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
|
319
|
+
The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
320
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
321
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429688\"><b>Mahabalipooram</b></A><br
|
322
|
+
/>Smith JM. <br /><i>JAMA The Journal of the American Medical Association,
|
323
|
+
Vol. , No. (2015) pp. - </i><br /><span class=\"paragraphSection\">The
|
324
|
+
extraordinary life of Edward Lear (1812-1888) seems to continue in spirit
|
325
|
+
across space and time from Victorian England to the present-day world, conveyed
|
326
|
+
in his captivating works. It may be amusing to consider that the same person
|
327
|
+
who concocted the whimsical poem “The Owl and the Pussy-cat” also
|
328
|
+
gave art lessons to the Queen. Ornithological illustrations were included
|
329
|
+
in his early oeuvre, with his later work featuring landscapes emanating the
|
330
|
+
allure of faraway lands. </span></p>]]></content:encoded>\r\n</item>\n<item
|
331
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429709\">\n<title>Diabetes
|
332
|
+
Remission After Bariatric Surgery</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429709</link>\r\n<description><span
|
333
|
+
class=\"paragraphSection\">Obese individuals with type 2 diabetes mellitus
|
334
|
+
experienced a remission of their diabetes after bariatric surgery followed
|
335
|
+
by 2 years of lifestyle weight loss intervention, according to a recent randomized
|
336
|
+
clinical trial. Those who had 3 years of lifestyle modification alone—1
|
337
|
+
year of intensive weight loss counseling followed by 2 years of twice-monthly
|
338
|
+
sessions focused on weight loss strategies—saw no remission of their
|
339
|
+
diabetes. The study provided important data on the surgical treatment of individuals
|
340
|
+
with class I obesity (body mass index of 30 to <35), who have previously
|
341
|
+
been excluded from bariatric surgical trials. The trial also assessed type
|
342
|
+
2 diabetes remission among individuals who received laparoscopic adjustable
|
343
|
+
gastric banding (LABG), a reversible and low-risk procedure that may be a
|
344
|
+
better surgical alternative for those with lower body mass index (Courcoulas
|
345
|
+
AP et al. <span style=\"font-style:italic;\">JAMA Surg</span>.
|
346
|
+
doi:<a href=\"http://jamanetwork.com/article.aspx'doi=10.1001/jamasurg.2015.1534\">10.1001/jamasurg.2015.1534</a>
|
347
|
+
[published online July 1, 2015]).</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429709</dc:identifier>\r\n<dc:creator>Slomski
|
348
|
+
A.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
|
349
|
+
The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
350
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
351
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429709\"><b>Diabetes
|
352
|
+
Remission After Bariatric Surgery</b></A><br />Slomski A. <br /><i>JAMA The
|
353
|
+
Journal of the American Medical Association, Vol. , No. (2015) pp. - </i><br
|
354
|
+
/><span class=\"paragraphSection\">Obese individuals with type 2 diabetes
|
355
|
+
mellitus experienced a remission of their diabetes after bariatric surgery
|
356
|
+
followed by 2 years of lifestyle weight loss intervention, according to a
|
357
|
+
recent randomized clinical trial. Those who had 3 years of lifestyle modification
|
358
|
+
alone—1 year of intensive weight loss counseling followed by 2 years
|
359
|
+
of twice-monthly sessions focused on weight loss strategies—saw no remission
|
360
|
+
of their diabetes. The study provided important data on the surgical treatment
|
361
|
+
of individuals with class I obesity (body mass index of 30 to <35), who
|
362
|
+
have previously been excluded from bariatric surgical trials. The trial also
|
363
|
+
assessed type 2 diabetes remission among individuals who received laparoscopic
|
364
|
+
adjustable gastric banding (LABG), a reversible and low-risk procedure that
|
365
|
+
may be a better surgical alternative for those with lower body mass index
|
366
|
+
(Courcoulas AP et al. <span style=\"font-style:italic;\">JAMA Surg</span>.
|
367
|
+
doi:<a href=\"http://jamanetwork.com/article.aspx'doi=10.1001/jamasurg.2015.1534\">10.1001/jamasurg.2015.1534</a>
|
368
|
+
[published online July 1, 2015]).</span></p>]]></content:encoded>\r\n</item>\n<item
|
369
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429699\">\n<title>CMS
|
370
|
+
Proposes Payment for Advance Care Planning Discussions</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429699</link>\r\n<description><span
|
371
|
+
class=\"paragraphSection\">The Centers for Medicare & Medicaid Services
|
372
|
+
(CMS) is seeking comment on a proposal to add separate payment rates and codes
|
373
|
+
for advance care planning conversations between Medicare beneficiaries and
|
374
|
+
physicians or other health care professionals paid under the Medicare Physician
|
375
|
+
Fee Schedule. Such discussions may cover, for example, information on treatment
|
376
|
+
options, advance directives, and forms patients need to complete to express
|
377
|
+
their wishes for end-of-life care. The proposal to offer paid benefit for
|
378
|
+
an initial 30-minute session on advance care planning and additional discussions
|
379
|
+
would “better enable seniors and other Medicare beneficiaries to make
|
380
|
+
important decisions that give them control over the type of care they receive
|
381
|
+
and when they receive it,” stated a CMS fact sheet (<a href=\"http://go.cms.gov/1KR7miD\">http://go.cms.gov/1KR7miD</a>).</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429699</dc:identifier>\r\n<dc:creator>Jacob
|
382
|
+
JA.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
|
383
|
+
The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
384
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
385
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429699\"><b>CMS
|
386
|
+
Proposes Payment for Advance Care Planning Discussions</b></A><br />Jacob
|
387
|
+
JA. <br /><i>JAMA The Journal of the American Medical Association, Vol. ,
|
388
|
+
No. (2015) pp. - </i><br /><span class=\"paragraphSection\">The Centers
|
389
|
+
for Medicare & Medicaid Services (CMS) is seeking comment on a proposal
|
390
|
+
to add separate payment rates and codes for advance care planning conversations
|
391
|
+
between Medicare beneficiaries and physicians or other health care professionals
|
392
|
+
paid under the Medicare Physician Fee Schedule. Such discussions may cover,
|
393
|
+
for example, information on treatment options, advance directives, and forms
|
394
|
+
patients need to complete to express their wishes for end-of-life care. The
|
395
|
+
proposal to offer paid benefit for an initial 30-minute session on advance
|
396
|
+
care planning and additional discussions would “better enable seniors
|
397
|
+
and other Medicare beneficiaries to make important decisions that give them
|
398
|
+
control over the type of care they receive and when they receive it,”
|
399
|
+
stated a CMS fact sheet (<a href=\"http://go.cms.gov/1KR7miD\">http://go.cms.gov/1KR7miD</a>).</span></p>]]></content:encoded>\r\n</item>\n<item
|
400
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429700\">\n<title>HHS
|
401
|
+
Establishes Training and Education Center for Ebola</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429700</link>\r\n<description><span
|
402
|
+
class=\"paragraphSection\">The Department of Health and Human Service (HHS)
|
403
|
+
has allocated $12 million in funds over the next 5 years for a new National
|
404
|
+
Ebola Training and Education Center (<a href=\"http://1.usa.gov/1dxrLug\">http://1.usa.gov/1dxrLug</a>).
|
405
|
+
The Center’s co-leaders—Emory University in Atlanta, University
|
406
|
+
of Nebraska Medical Center in Omaha, and Bellevue Hospital Center in New York
|
407
|
+
City—will receive the funding to develop and teach courses in caring
|
408
|
+
for patients with Ebola and other serious infectious diseases based on evidence-based
|
409
|
+
best practices. The training will be offered to state health departments and
|
410
|
+
health care facilities.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429700</dc:identifier>\r\n<dc:creator>Jacob
|
411
|
+
JA.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
|
412
|
+
The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
413
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
414
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429700\"><b>HHS
|
415
|
+
Establishes Training and Education Center for Ebola</b></A><br />Jacob JA.
|
416
|
+
<br /><i>JAMA The Journal of the American Medical Association, Vol. , No.
|
417
|
+
\ (2015) pp. - </i><br /><span class=\"paragraphSection\">The Department
|
418
|
+
of Health and Human Service (HHS) has allocated $12 million in funds over
|
419
|
+
the next 5 years for a new National Ebola Training and Education Center (<a
|
420
|
+
href=\"http://1.usa.gov/1dxrLug\">http://1.usa.gov/1dxrLug</a>).
|
421
|
+
The Center’s co-leaders—Emory University in Atlanta, University
|
422
|
+
of Nebraska Medical Center in Omaha, and Bellevue Hospital Center in New York
|
423
|
+
City—will receive the funding to develop and teach courses in caring
|
424
|
+
for patients with Ebola and other serious infectious diseases based on evidence-based
|
425
|
+
best practices. The training will be offered to state health departments and
|
426
|
+
health care facilities.</span></p>]]></content:encoded>\r\n</item>\n<item
|
427
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429695\">\n<title>Pediatric
|
428
|
+
Pulseless Arrest With “Nonshockable” Rhythm</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429695</link>\r\n<description><span
|
429
|
+
class=\"paragraphSection\">In this issue of <span style=\"font-style:italic;\">JAMA</span>,
|
430
|
+
Andersen et al report findings from their observational study based on data
|
431
|
+
from a national registry of 15 959 pediatric (<18 years) in-hospital
|
432
|
+
cardiac arrests from 2000 to 2014, which included 1558 children (9.8%) who
|
433
|
+
received at least 1 dose of epinephrine for nonshockable rhythms (ie, pulseless
|
434
|
+
electrical activity or asystole) during cardiopulmonary resuscitation (CPR).
|
435
|
+
Among these children (median age, 9 months), 50% received epinephrine during
|
436
|
+
the same whole minute as the patient lost their pulse or the next whole minute;
|
437
|
+
only 15% received the first dose of epinephrine after 5 minutes of CPR. In
|
438
|
+
children receiving epinephrine for nonshockable rhythms, the authors found
|
439
|
+
that each minute of delay in epinephrine administration was associated with
|
440
|
+
adverse outcomes (ie, lower risk of return of spontaneous circulation [ROSC],
|
441
|
+
survival at 24 hours, and discharge from hospital with favorable outcome).</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429695</dc:identifier>\r\n<dc:creator>Tasker
|
442
|
+
RC</dc:creator>\n<dc:creator>Randolph AG.</dc:creator>\n<dc:publisher>American
|
443
|
+
Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
|
444
|
+
of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
445
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
446
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429695\"><b>Pediatric
|
447
|
+
Pulseless Arrest With “Nonshockable” Rhythm</b></A><br />Tasker
|
448
|
+
RC Randolph AG.<br /><i>JAMA The Journal of the American Medical Association,
|
449
|
+
Vol. , No. (2015) pp. - </i><br /><span class=\"paragraphSection\">In
|
450
|
+
this issue of <span style=\"font-style:italic;\">JAMA</span>,
|
451
|
+
Andersen et al report findings from their observational study based on data
|
452
|
+
from a national registry of 15 959 pediatric (<18 years) in-hospital
|
453
|
+
cardiac arrests from 2000 to 2014, which included 1558 children (9.8%) who
|
454
|
+
received at least 1 dose of epinephrine for nonshockable rhythms (ie, pulseless
|
455
|
+
electrical activity or asystole) during cardiopulmonary resuscitation (CPR).
|
456
|
+
Among these children (median age, 9 months), 50% received epinephrine during
|
457
|
+
the same whole minute as the patient lost their pulse or the next whole minute;
|
458
|
+
only 15% received the first dose of epinephrine after 5 minutes of CPR. In
|
459
|
+
children receiving epinephrine for nonshockable rhythms, the authors found
|
460
|
+
that each minute of delay in epinephrine administration was associated with
|
461
|
+
adverse outcomes (ie, lower risk of return of spontaneous circulation [ROSC],
|
462
|
+
survival at 24 hours, and discharge from hospital with favorable outcome).</span></p>]]></content:encoded>\r\n</item>\n<item
|
463
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429691\">\n<title>Lines
|
464
|
+
Omitted From Table</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429691</link>\r\n<description><span
|
465
|
+
class=\"paragraphSection\">In the Original Investigation entitled “Mortality,
|
466
|
+
Hospitalizations, and Expenditures for the Medicare Population Aged 65 Years
|
467
|
+
or Older, 1999-2013” published in the July 28, 2015, issue of <span
|
468
|
+
style=\"font-style:italic;\">JAMA</span>, the last 2 rows of Table
|
469
|
+
2 (Expired and Others for 2007-2013) were inadvertently omitted. This article
|
470
|
+
was corrected online.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429691</dc:identifier>\r\n<dc:publisher>American
|
471
|
+
Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
|
472
|
+
of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
473
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
474
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429691\"><b>Lines
|
475
|
+
Omitted From Table</b></A><br /> <br /><i>JAMA The Journal of the American
|
476
|
+
Medical Association, Vol. , No. (2015) pp. - </i><br /><span class=\"paragraphSection\">In
|
477
|
+
the Original Investigation entitled “Mortality, Hospitalizations, and
|
478
|
+
Expenditures for the Medicare Population Aged 65 Years or Older, 1999-2013”
|
479
|
+
published in the July 28, 2015, issue of <span style=\"font-style:italic;\">JAMA</span>,
|
480
|
+
the last 2 rows of Table 2 (Expired and Others for 2007-2013) were inadvertently
|
481
|
+
omitted. This article was corrected online.</span></p>]]></content:encoded>\r\n</item>\n<item
|
482
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2424669\">\n<title>Safety
|
483
|
+
and Fairness in the Right-to-Try</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2424669</link>\r\n<description><span
|
484
|
+
class=\"paragraphSection\">This Medical News and Perspectives article discusses
|
485
|
+
issues surrounding Right-to-Try laws that allow patients with terminal illness
|
486
|
+
to petition for access to investigational drugs and therapies.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2424669</dc:identifier>\r\n<dc:creator>Jacob
|
487
|
+
JA.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
|
488
|
+
The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
489
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
490
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2424669\"><b>Safety
|
491
|
+
and Fairness in the Right-to-Try</b></A><br />Jacob JA. <br /><i>JAMA The
|
492
|
+
Journal of the American Medical Association, Vol. , No. (2015) pp. - </i><br
|
493
|
+
/><span class=\"paragraphSection\">This Medical News and Perspectives
|
494
|
+
article discusses issues surrounding Right-to-Try laws that allow patients
|
495
|
+
with terminal illness to petition for access to investigational drugs and
|
496
|
+
therapies.</span></p>]]></content:encoded>\r\n</item>\n<item rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429711\">\n<title>Bridging
|
497
|
+
Anticoagulation Offers No Benefit</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429711</link>\r\n<description><span
|
498
|
+
class=\"paragraphSection\">A recent trial found that among patients with
|
499
|
+
atrial fibrillation (AF) who stopped taking warfarin before undergoing an
|
500
|
+
elective surgery or invasive procedure, forgoing bridging anticoagulation
|
501
|
+
was noninferior to perioperative bridging with low-molecular-weight heparin
|
502
|
+
to prevent arterial thromboembolism. Bridging also nearly tripled the risk
|
503
|
+
of major bleeding without providing benefit in preventing myocardial infarction,
|
504
|
+
venous thromboembolism, or death when compared with no bridging (Douketis
|
505
|
+
JD et al. <span style=\"font-style:italic;\">N Engl J Med</span>.
|
506
|
+
doi:<a href=\"http://dx.doi.org/10.1056/NEJMoa1501035\">10.1056/NEJMoa1501035</a>
|
507
|
+
[published online June 22, 2015]).</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429711</dc:identifier>\r\n<dc:creator>Slomski
|
508
|
+
A.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
|
509
|
+
The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
510
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
511
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429711\"><b>Bridging
|
512
|
+
Anticoagulation Offers No Benefit</b></A><br />Slomski A. <br /><i>JAMA The
|
513
|
+
Journal of the American Medical Association, Vol. , No. (2015) pp. - </i><br
|
514
|
+
/><span class=\"paragraphSection\">A recent trial found that among patients
|
515
|
+
with atrial fibrillation (AF) who stopped taking warfarin before undergoing
|
516
|
+
an elective surgery or invasive procedure, forgoing bridging anticoagulation
|
517
|
+
was noninferior to perioperative bridging with low-molecular-weight heparin
|
518
|
+
to prevent arterial thromboembolism. Bridging also nearly tripled the risk
|
519
|
+
of major bleeding without providing benefit in preventing myocardial infarction,
|
520
|
+
venous thromboembolism, or death when compared with no bridging (Douketis
|
521
|
+
JD et al. <span style=\"font-style:italic;\">N Engl J Med</span>.
|
522
|
+
doi:<a href=\"http://dx.doi.org/10.1056/NEJMoa1501035\">10.1056/NEJMoa1501035</a>
|
523
|
+
[published online June 22, 2015]).</span></p>]]></content:encoded>\r\n</item>\n<item
|
524
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429710\">\n<title>Diabetes
|
525
|
+
Drug Promotes Weight Loss in Patients</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429710</link>\r\n<description><span
|
526
|
+
class=\"paragraphSection\">Results from a recent placebo-controlled trial
|
527
|
+
suggest liraglutide, a glucagon-like peptide-1 analogue approved to treat
|
528
|
+
type 2 diabetes, can help shed body weight and improve glycemic control among
|
529
|
+
people who were very overweight or obese—but not diabetic. The trial,
|
530
|
+
consisting of 3731 participants, also found that participants who had taken
|
531
|
+
liraglutide had a significantly lower incidence of prediabetes after 56 weeks
|
532
|
+
and developed type 2 diabetes at a significantly lower rate compared with
|
533
|
+
participants taking placebo (Pi-Sunyer X et al. <span style=\"font-style:italic;\">N
|
534
|
+
Engl J Med</span>. 2015;373[1]:11-22).</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429710</dc:identifier>\r\n<dc:creator>Slomski
|
535
|
+
A.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
|
536
|
+
The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
537
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
538
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429710\"><b>Diabetes
|
539
|
+
Drug Promotes Weight Loss in Patients</b></A><br />Slomski A. <br /><i>JAMA
|
540
|
+
The Journal of the American Medical Association, Vol. , No. (2015) pp. -
|
541
|
+
</i><br /><span class=\"paragraphSection\">Results from a recent placebo-controlled
|
542
|
+
trial suggest liraglutide, a glucagon-like peptide-1 analogue approved to
|
543
|
+
treat type 2 diabetes, can help shed body weight and improve glycemic control
|
544
|
+
among people who were very overweight or obese—but not diabetic. The
|
545
|
+
trial, consisting of 3731 participants, also found that participants who had
|
546
|
+
taken liraglutide had a significantly lower incidence of prediabetes after
|
547
|
+
56 weeks and developed type 2 diabetes at a significantly lower rate compared
|
548
|
+
with participants taking placebo (Pi-Sunyer X et al. <span style=\"font-style:italic;\">N
|
549
|
+
Engl J Med</span>. 2015;373[1]:11-22).</span></p>]]></content:encoded>\r\n</item>\n<item
|
550
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429694\">\n<title>Optimizing
|
551
|
+
Cognitive Health in Older Individuals</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429694</link>\r\n<description><span
|
552
|
+
class=\"paragraphSection\">Loss of cognitive function and the development
|
553
|
+
of dementia are among the greatest concerns confronting older individuals.
|
554
|
+
As populations around the world age, the global prevalence of dementia is
|
555
|
+
predicted to increase substantially from an estimated 35.6 million in 2010
|
556
|
+
to 65.7 million in 2030, and 115.4 million in 2050. In the United States in
|
557
|
+
1990, Alzheimer disease ranked 25th in terms of disability-adjusted life-years
|
558
|
+
lost. In 2010, it ranked 12th, with the greatest median percentage change
|
559
|
+
of any of the leading 30 diseases. The burden of mild cognitive impairment
|
560
|
+
(MCI) is even larger. Discussions between physicians and patients about strategies
|
561
|
+
to prevent cognitive decline and dementia have become commonplace, and there
|
562
|
+
is great interest in new evidence of lifestyle modifications that might improve
|
563
|
+
cognitive aging and prevent the onset of dementia. These lifestyle modifications
|
564
|
+
include exercise, dietary changes, cognitive training (ie, “brain games”),
|
565
|
+
and multimodal treatments. A meta-analysis of observational studies found
|
566
|
+
that the modifiable risk factors that have most consistently been associated
|
567
|
+
with a reduced risk of dementia include higher educational attainment, increased
|
568
|
+
physical activity, and avoidance of smoking.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429694</dc:identifier>\r\n<dc:creator>Gill
|
569
|
+
SS</dc:creator>\n<dc:creator>Seitz DP.</dc:creator>\n<dc:publisher>American
|
570
|
+
Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
|
571
|
+
of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
572
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
573
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429694\"><b>Optimizing
|
574
|
+
Cognitive Health in Older Individuals</b></A><br />Gill SS Seitz DP.<br /><i>JAMA
|
575
|
+
The Journal of the American Medical Association, Vol. , No. (2015) pp. -
|
576
|
+
</i><br /><span class=\"paragraphSection\">Loss of cognitive function
|
577
|
+
and the development of dementia are among the greatest concerns confronting
|
578
|
+
older individuals. As populations around the world age, the global prevalence
|
579
|
+
of dementia is predicted to increase substantially from an estimated 35.6
|
580
|
+
million in 2010 to 65.7 million in 2030, and 115.4 million in 2050. In the
|
581
|
+
United States in 1990, Alzheimer disease ranked 25th in terms of disability-adjusted
|
582
|
+
life-years lost. In 2010, it ranked 12th, with the greatest median percentage
|
583
|
+
change of any of the leading 30 diseases. The burden of mild cognitive impairment
|
584
|
+
(MCI) is even larger. Discussions between physicians and patients about strategies
|
585
|
+
to prevent cognitive decline and dementia have become commonplace, and there
|
586
|
+
is great interest in new evidence of lifestyle modifications that might improve
|
587
|
+
cognitive aging and prevent the onset of dementia. These lifestyle modifications
|
588
|
+
include exercise, dietary changes, cognitive training (ie, “brain games”),
|
589
|
+
and multimodal treatments. A meta-analysis of observational studies found
|
590
|
+
that the modifiable risk factors that have most consistently been associated
|
591
|
+
with a reduced risk of dementia include higher educational attainment, increased
|
592
|
+
physical activity, and avoidance of smoking.</span></p>]]></content:encoded>\r\n</item>\n<item
|
593
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429706\">\n<title>Opioid
|
594
|
+
Dependence Treatment in the Emergency Department</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429706</link>\r\n<description><span
|
595
|
+
class=\"paragraphSection\"><strong>In Reply</strong> Dr Swartz
|
596
|
+
provides an opportunity to discuss the fundamental principles of clinical
|
597
|
+
research and opioid dependence treatment that guided our study. Clinical trial
|
598
|
+
design involves selecting a primary, clinically important outcome at a point
|
599
|
+
in time. Our primary outcome was engagement in treatment at 30 days. We chose
|
600
|
+
engagement in treatment as the primary outcome because it is associated with
|
601
|
+
decreased criminal activity, HIV transmission, and mortality.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429706</dc:identifier>\r\n<dc:creator>Fiellin
|
602
|
+
DA</dc:creator>\n<dc:creator>O&#8217;Connor PG, D&#8217;Onofrio G.</dc:creator>\n<dc:publisher>American
|
603
|
+
Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
|
604
|
+
of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
605
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
606
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429706\"><b>Opioid
|
607
|
+
Dependence Treatment in the Emergency Department</b></A><br />Fiellin DA O’Connor
|
608
|
+
PG, D’Onofrio G.<br /><i>JAMA The Journal of the American Medical Association,
|
609
|
+
Vol. , No. (2015) pp. - </i><br /><span class=\"paragraphSection\"><strong>In
|
610
|
+
Reply</strong> Dr Swartz provides an opportunity to discuss the fundamental
|
611
|
+
principles of clinical research and opioid dependence treatment that guided
|
612
|
+
our study. Clinical trial design involves selecting a primary, clinically
|
613
|
+
important outcome at a point in time. Our primary outcome was engagement in
|
614
|
+
treatment at 30 days. We chose engagement in treatment as the primary outcome
|
615
|
+
because it is associated with decreased criminal activity, HIV transmission,
|
616
|
+
and mortality.</span></p>]]></content:encoded>\r\n</item>\n<item rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429705\">\n<title>Etiologies
|
617
|
+
of Tattoo Lesions</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429705</link>\r\n<description><span
|
618
|
+
class=\"paragraphSection\"><strong>To the Editor</strong> Dr
|
619
|
+
Ayoola and colleagues described a patient with systemic sarcoidosis presenting
|
620
|
+
with skin lesions of his tattoos. The authors stated that the differential
|
621
|
+
diagnosis of the skin lesions included drug eruptions, T-cell lymphoma, and
|
622
|
+
tuberculosis. However, other possibilities should have been considered.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429705</dc:identifier>\r\n<dc:creator>Han
|
623
|
+
F.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
|
624
|
+
The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
625
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
626
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429705\"><b>Etiologies
|
627
|
+
of Tattoo Lesions</b></A><br />Han F. <br /><i>JAMA The Journal of the American
|
628
|
+
Medical Association, Vol. , No. (2015) pp. - </i><br /><span class=\"paragraphSection\"><strong>To
|
629
|
+
the Editor</strong> Dr Ayoola and colleagues described a patient with
|
630
|
+
systemic sarcoidosis presenting with skin lesions of his tattoos. The authors
|
631
|
+
stated that the differential diagnosis of the skin lesions included drug eruptions,
|
632
|
+
T-cell lymphoma, and tuberculosis. However, other possibilities should have
|
633
|
+
been considered.</span></p>]]></content:encoded>\r\n</item>\n<item rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429707\">\n<title>Etiologies
|
634
|
+
of Tattoo Lesions</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429707</link>\r\n<description><span
|
635
|
+
class=\"paragraphSection\"><strong>In Reply</strong> Mr Han
|
636
|
+
raises questions about the differential diagnosis of cutaneous manifestations
|
637
|
+
of sarcoidosis in tattoos. We included drug eruptions, T-cell lymphoma, and
|
638
|
+
tuberculosis as differential diagnoses for our patient with tattoo sarcoidosis.
|
639
|
+
One of the most common differential diagnoses is foreign body granuloma. These
|
640
|
+
reactions are attributable to the pigment in tattoo ink. Histologically they
|
641
|
+
can be differentiated by the presence of foreign bodies. Generally, reactions
|
642
|
+
to single pigments are found in foreign body granulomas; if multiple pigments
|
643
|
+
are involved, systemic sarcoidosis is more likely.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429707</dc:identifier>\r\n<dc:creator>Jamindar
|
644
|
+
P</dc:creator>\n<dc:creator>Powner J</dc:creator>\n<dc:creator>Ayoola R.</dc:creator>\n<dc:publisher>American
|
645
|
+
Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
|
646
|
+
of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
647
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
648
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429707\"><b>Etiologies
|
649
|
+
of Tattoo Lesions</b></A><br />Jamindar P Powner J, Ayoola R.<br /><i>JAMA
|
650
|
+
The Journal of the American Medical Association, Vol. , No. (2015) pp. -
|
651
|
+
</i><br /><span class=\"paragraphSection\"><strong>In Reply</strong>
|
652
|
+
Mr Han raises questions about the differential diagnosis of cutaneous manifestations
|
653
|
+
of sarcoidosis in tattoos. We included drug eruptions, T-cell lymphoma, and
|
654
|
+
tuberculosis as differential diagnoses for our patient with tattoo sarcoidosis.
|
655
|
+
One of the most common differential diagnoses is foreign body granuloma. These
|
656
|
+
reactions are attributable to the pigment in tattoo ink. Histologically they
|
657
|
+
can be differentiated by the presence of foreign bodies. Generally, reactions
|
658
|
+
to single pigments are found in foreign body granulomas; if multiple pigments
|
659
|
+
are involved, systemic sarcoidosis is more likely.</span></p>]]></content:encoded>\r\n</item>\n<item
|
660
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429690\">\n<title>Incorrect
|
661
|
+
Study Name</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429690</link>\r\n<description><span
|
662
|
+
class=\"paragraphSection\">In the Review Article entitled “Stroke
|
663
|
+
Prevention in Atrial Fibrillation: A Systematic Review” in the May 19,
|
664
|
+
2015, issue of <span style=\"font-style:italic;\">JAMA</span>,
|
665
|
+
the ARISTOLE trial was incorrectly expanded. It should have read “Apixaban
|
666
|
+
for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation.”
|
667
|
+
This article was corrected online.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429690</dc:identifier>\r\n<dc:publisher>American
|
668
|
+
Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
|
669
|
+
of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
670
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
671
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429690\"><b>Incorrect
|
672
|
+
Study Name</b></A><br /> <br /><i>JAMA The Journal of the American Medical
|
673
|
+
Association, Vol. , No. (2015) pp. - </i><br /><span class=\"paragraphSection\">In
|
674
|
+
the Review Article entitled “Stroke Prevention in Atrial Fibrillation:
|
675
|
+
A Systematic Review” in the May 19, 2015, issue of <span style=\"font-style:italic;\">JAMA</span>,
|
676
|
+
the ARISTOLE trial was incorrectly expanded. It should have read “Apixaban
|
677
|
+
for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation.”
|
678
|
+
This article was corrected online.</span></p>]]></content:encoded>\r\n</item>\n<item
|
679
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429689\">\n<title>Incorrect
|
680
|
+
Values Reported</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429689</link>\r\n<description><span
|
681
|
+
class=\"paragraphSection\">In the Original Investigation entitled “Cannabinoids
|
682
|
+
for Medical Use: A Systematic Review and Meta-analysis” published in
|
683
|
+
the June 23/30, 2015, issue of <span style=\"font-style:italic;\">JAMA</span>,
|
684
|
+
the value for the average reduction in the Ashworth spasticity scale should
|
685
|
+
have been reported as “weighted mean difference, −0.12 (95% CI,
|
686
|
+
−0.24 to 0.01); 5 trials.” This article was corrected online.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429689</dc:identifier>\r\n<dc:publisher>American
|
687
|
+
Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
|
688
|
+
of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
689
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
690
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429689\"><b>Incorrect
|
691
|
+
Values Reported</b></A><br /> <br /><i>JAMA The Journal of the American Medical
|
692
|
+
Association, Vol. , No. (2015) pp. - </i><br /><span class=\"paragraphSection\">In
|
693
|
+
the Original Investigation entitled “Cannabinoids for Medical Use: A
|
694
|
+
Systematic Review and Meta-analysis” published in the June 23/30, 2015,
|
695
|
+
issue of <span style=\"font-style:italic;\">JAMA</span>, the value
|
696
|
+
for the average reduction in the Ashworth spasticity scale should have been
|
697
|
+
reported as “weighted mean difference, −0.12 (95% CI, −0.24
|
698
|
+
to 0.01); 5 trials.” This article was corrected online.</span></p>]]></content:encoded>\r\n</item>\n<item
|
699
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429713\">\n<title>Effect
|
700
|
+
of Nutrient Supplementation on Cognitive Function</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429713</link>\r\n<description><span
|
701
|
+
class=\"paragraphSection\">This randomized trial reports that among older
|
702
|
+
individuals with age-related macular degeneration supplements containing long-chain
|
703
|
+
fatty acids and/or lutein and zeaxanthin had no effect on cognitive function.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429713</dc:identifier>\r\n<dc:creator>Chew
|
704
|
+
EY</dc:creator>\n<dc:creator>Clemons TE, Agr&#243;n E, et al.</dc:creator>\n<dc:publisher>American
|
705
|
+
Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
|
706
|
+
of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
707
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
708
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429713\"><b>Effect
|
709
|
+
of Nutrient Supplementation on Cognitive Function</b></A><br />Chew EY Clemons
|
710
|
+
TE, Agrón E, et al.<br /><i>JAMA The Journal of the American Medical
|
711
|
+
Association, Vol. , No. (2015) pp. - </i><br /><span class=\"paragraphSection\">This
|
712
|
+
randomized trial reports that among older individuals with age-related macular
|
713
|
+
degeneration supplements containing long-chain fatty acids and/or lutein and
|
714
|
+
zeaxanthin had no effect on cognitive function.</span></p>]]></content:encoded>\r\n</item>\n<item
|
715
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429714\">\n<title>Time
|
716
|
+
to Epinephrine After Pediatric In-Hospital Cardiac Arrest</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429714</link>\r\n<description><span
|
717
|
+
class=\"paragraphSection\">This study uses data for pediatric patients
|
718
|
+
from the Get With the Guidelines–Resuscitation registry to report associations
|
719
|
+
between delay in epinephrine and survival and neurological outcome after pediatric
|
720
|
+
in-hospital cardiac arrest.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429714</dc:identifier>\r\n<dc:creator>Andersen
|
721
|
+
LW</dc:creator>\n<dc:creator>Berg KM</dc:creator>\n<dc:creator>Saindon BZ</dc:creator>\n<dc:creator>et
|
722
|
+
al.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
|
723
|
+
The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
724
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
725
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429714\"><b>Time
|
726
|
+
to Epinephrine After Pediatric In-Hospital Cardiac Arrest</b></A><br />Andersen
|
727
|
+
LW Berg KM, Saindon BZ, et al.<br /><i>JAMA The Journal of the American
|
728
|
+
Medical Association, Vol. , No. (2015) pp. - </i><br /><span class=\"paragraphSection\">This
|
729
|
+
study uses data for pediatric patients from the Get With the Guidelines–Resuscitation
|
730
|
+
registry to report associations between delay in epinephrine and survival
|
731
|
+
and neurological outcome after pediatric in-hospital cardiac arrest.</span></p>]]></content:encoded>\r\n</item>\n<item
|
732
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429715\">\n<title>Mutation
|
733
|
+
Clearance After Chemotherapy and Outcomes in AML</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429715</link>\r\n<description><span
|
734
|
+
class=\"paragraphSection\">This cohort study investigates clearance patterns
|
735
|
+
of somatic mutations in acute myeloid leukemia patients given induction chemotherapy,
|
736
|
+
and associations between those patterns and clinical outcomes.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429715</dc:identifier>\r\n<dc:creator>Klco
|
737
|
+
JM</dc:creator>\n<dc:creator>Miller CA</dc:creator>\n<dc:creator>Griffith
|
738
|
+
M</dc:creator>\n<dc:creator>et al.</dc:creator>\n<dc:publisher>American Medical
|
739
|
+
Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal of the
|
740
|
+
American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
741
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
742
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429715\"><b>Mutation
|
743
|
+
Clearance After Chemotherapy and Outcomes in AML</b></A><br />Klco JM Miller
|
744
|
+
CA, Griffith M, et al.<br /><i>JAMA The Journal of the American Medical
|
745
|
+
Association, Vol. , No. (2015) pp. - </i><br /><span class=\"paragraphSection\">This
|
746
|
+
cohort study investigates clearance patterns of somatic mutations in acute
|
747
|
+
myeloid leukemia patients given induction chemotherapy, and associations between
|
748
|
+
those patterns and clinical outcomes.</span></p>]]></content:encoded>\r\n</item>\n<item
|
749
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429696\">\n<title>Engaging
|
750
|
+
Primary Care Clinicians in Early Obesity Prevention Research</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429696</link>\r\n<description><span
|
751
|
+
class=\"paragraphSection\">This commentary describes a report published
|
752
|
+
in <span style=\"font-style:italic;\">JAMA Pediatrics</span> summarizing
|
753
|
+
a National Institutes of Health workshop about primary care clinician involvement
|
754
|
+
in preventing early childhood obesity.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429696</dc:identifier>\r\n<dc:creator>Faith
|
755
|
+
MS</dc:creator>\n<dc:creator>Stettler N</dc:creator>\n<dc:creator>Pietrobelli
|
756
|
+
A.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
|
757
|
+
The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
758
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
759
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429696\"><b>Engaging
|
760
|
+
Primary Care Clinicians in Early Obesity Prevention Research</b></A><br />Faith
|
761
|
+
MS Stettler N, Pietrobelli A.<br /><i>JAMA The Journal of the American Medical
|
762
|
+
Association, Vol. , No. (2015) pp. - </i><br /><span class=\"paragraphSection\">This
|
763
|
+
commentary describes a report published in <span style=\"font-style:italic;\">JAMA
|
764
|
+
Pediatrics</span> summarizing a National Institutes of Health workshop
|
765
|
+
about primary care clinician involvement in preventing early childhood obesity.</span></p>]]></content:encoded>\r\n</item>\n<item
|
766
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429697\">\n<title>Prostate
|
767
|
+
Cancer Screening</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429697</link>\r\n<description><span
|
768
|
+
class=\"paragraphSection\">This JAMA Clinical Guidelines Synopsis summarizes
|
769
|
+
the US Preventive Services Task Force’s (2012) and American Urological
|
770
|
+
Association’s (2013) clinical practice guidelines for prostate cancer
|
771
|
+
screening.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429697</dc:identifier>\r\n<dc:creator>Eggener
|
772
|
+
SE</dc:creator>\n<dc:creator>Cifu AS</dc:creator>\n<dc:creator>Nabhan C.</dc:creator>\n<dc:publisher>American
|
773
|
+
Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
|
774
|
+
of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
775
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
776
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429697\"><b>Prostate
|
777
|
+
Cancer Screening</b></A><br />Eggener SE Cifu AS, Nabhan C.<br /><i>JAMA
|
778
|
+
The Journal of the American Medical Association, Vol. , No. (2015) pp. -
|
779
|
+
</i><br /><span class=\"paragraphSection\">This JAMA Clinical Guidelines
|
780
|
+
Synopsis summarizes the US Preventive Services Task Force’s (2012) and
|
781
|
+
American Urological Association’s (2013) clinical practice guidelines
|
782
|
+
for prostate cancer screening.</span></p>]]></content:encoded>\r\n</item>\n<item
|
783
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429692\">\n<title>Clinical
|
784
|
+
Significance of Positive Antinuclear Antibody Test</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429692</link>\r\n<description><span
|
785
|
+
class=\"paragraphSection\">A 30-year-old woman with polyarthralgias responsive
|
786
|
+
to celecoxib has an ANA titer of 1:80. How do you interpret this test result'</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429692</dc:identifier>\r\n<dc:creator>Fatemi
|
787
|
+
G</dc:creator>\n<dc:creator>Kermani TA.</dc:creator>\n<dc:publisher>American
|
788
|
+
Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
|
789
|
+
of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
790
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
791
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429692\"><b>Clinical
|
792
|
+
Significance of Positive Antinuclear Antibody Test</b></A><br />Fatemi G Kermani
|
793
|
+
TA.<br /><i>JAMA The Journal of the American Medical Association, Vol. , No.
|
794
|
+
\ (2015) pp. - </i><br /><span class=\"paragraphSection\">A 30-year-old
|
795
|
+
woman with polyarthralgias responsive to celecoxib has an ANA titer of 1:80.
|
796
|
+
How do you interpret this test result'</span></p>]]></content:encoded>\r\n</item>\n<item
|
797
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429703\">\n<title>Military
|
798
|
+
Misconduct and Homelessness Among US Veterans, 2001-2012</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429703</link>\r\n<description><span
|
799
|
+
class=\"paragraphSection\">This study used Veterans Health Administration
|
800
|
+
data to investigate the association between misconduct-related separations
|
801
|
+
and homelessness among recently returned active-duty US military service members.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429703</dc:identifier>\r\n<dc:creator>Gundlapalli
|
802
|
+
AV</dc:creator>\n<dc:creator>Fargo JD</dc:creator>\n<dc:creator>Metraux S</dc:creator>\n<dc:creator>et
|
803
|
+
al.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
|
804
|
+
The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
805
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
806
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429703\"><b>Military
|
807
|
+
Misconduct and Homelessness Among US Veterans, 2001-2012</b></A><br />Gundlapalli
|
808
|
+
AV Fargo JD, Metraux S, et al.<br /><i>JAMA The Journal of the American
|
809
|
+
Medical Association, Vol. , No. (2015) pp. - </i><br /><span class=\"paragraphSection\">This
|
810
|
+
study used Veterans Health Administration data to investigate the association
|
811
|
+
between misconduct-related separations and homelessness among recently returned
|
812
|
+
active-duty US military service members.</span></p>]]></content:encoded>\r\n</item>\n<item
|
813
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429704\">\n<title>Opioid
|
814
|
+
Dependence Treatment in the Emergency Department</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429704</link>\r\n<description><span
|
815
|
+
class=\"paragraphSection\"><strong>To the Editor</strong> In
|
816
|
+
the article about emergency department (ED)–initiated buprenorphine/naloxone
|
817
|
+
treatment for opioid dependence, Dr D’Onofrio and colleagues omitted
|
818
|
+
important information and then focused on the most optimistic outcomes to
|
819
|
+
infer a benefit.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429704</dc:identifier>\r\n<dc:creator>Swartz
|
820
|
+
AW.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
|
821
|
+
The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
822
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
823
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429704\"><b>Opioid
|
824
|
+
Dependence Treatment in the Emergency Department</b></A><br />Swartz AW. <br
|
825
|
+
/><i>JAMA The Journal of the American Medical Association, Vol. , No. (2015)
|
826
|
+
pp. - </i><br /><span class=\"paragraphSection\"><strong>To the
|
827
|
+
Editor</strong> In the article about emergency department (ED)–initiated
|
828
|
+
buprenorphine/naloxone treatment for opioid dependence, Dr D’Onofrio
|
829
|
+
and colleagues omitted important information and then focused on the most
|
830
|
+
optimistic outcomes to infer a benefit.</span></p>]]></content:encoded>\r\n</item>\n<item
|
831
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429701\">\n<title>Highlights
|
832
|
+
for August 25, 2015</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429701</link>\r\n<description><br>\nArticle
|
833
|
+
URL: http://jama.jamanetwork.com/article.aspx?articleID=2429701<br>\nCitation:
|
834
|
+
\ (2015) <br>\nPublication Date: Tue, 25 Aug 2015 00:00:00 GMT<br>\nJournal:
|
835
|
+
JAMA The Journal of the American Medical Association</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429701</dc:identifier>\r\n<dc:publisher>American
|
836
|
+
Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
|
837
|
+
of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
838
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
839
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429701\"><b>Highlights
|
840
|
+
for August 25, 2015</b></A><br /> <br /><i>JAMA The Journal of the American
|
841
|
+
Medical Association, Vol. , No. (2015) pp. - </i><br />\nArticle URL: http://jama.jamanetwork.com/article.aspx?articleID=2429701\nCitation:
|
842
|
+
\ (2015) \nPublication Date: Tue, 25 Aug 2015 00:00:00 GMT\nJournal: JAMA
|
843
|
+
The Journal of the American Medical Association</p>]]></content:encoded>\r\n</item>\n<item
|
844
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2338495\">\n<title>Sexual
|
845
|
+
Health in America</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2338495</link>\r\n<description><span
|
846
|
+
class=\"paragraphSection\">This Viewpoint discusses a framework for improving
|
847
|
+
patient care and public sexual health.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2338495</dc:identifier>\r\n<dc:creator>Satcher
|
848
|
+
D</dc:creator>\n<dc:creator>Hook EW</dc:creator>\n<dc:creator>III</dc:creator>\n<dc:creator>Coleman
|
849
|
+
E.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
|
850
|
+
The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
851
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
852
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2338495\"><b>Sexual
|
853
|
+
Health in America</b></A><br />Satcher D Hook EW, III, Coleman E.<br /><i>JAMA
|
854
|
+
The Journal of the American Medical Association, Vol. , No. (2015) pp. -
|
855
|
+
</i><br /><span class=\"paragraphSection\">This Viewpoint discusses
|
856
|
+
a framework for improving patient care and public sexual health.</span></p>]]></content:encoded>\r\n</item>\n<item
|
857
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429723\">\n<title>Fusing
|
858
|
+
Randomized Trials With Big Data</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429723</link>\r\n<description><span
|
859
|
+
class=\"paragraphSection\">This Viewpoint proposes ways that electronic
|
860
|
+
health records and other “big data” can be integrated with randomized
|
861
|
+
trial designs to leverage the strengths of both for research inferences.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429723</dc:identifier>\r\n<dc:creator>Angus
|
862
|
+
DC.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
|
863
|
+
The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
864
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
865
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429723\"><b>Fusing
|
866
|
+
Randomized Trials With Big Data</b></A><br />Angus DC. <br /><i>JAMA The Journal
|
867
|
+
of the American Medical Association, Vol. , No. (2015) pp. - </i><br /><span
|
868
|
+
class=\"paragraphSection\">This Viewpoint proposes ways that electronic
|
869
|
+
health records and other “big data” can be integrated with randomized
|
870
|
+
trial designs to leverage the strengths of both for research inferences.</span></p>]]></content:encoded>\r\n</item>\n<item
|
871
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2319350\">\n<title>Quality
|
872
|
+
Metrics for Physical and Behavioral Health Care Integration</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2319350</link>\r\n<description><span
|
873
|
+
class=\"paragraphSection\">This Viewpoint discusses developing quality
|
874
|
+
metrics in behavioral and general health care to encourage more cost-effective
|
875
|
+
care and improve the status quo.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2319350</dc:identifier>\r\n<dc:creator>Goldman
|
876
|
+
ML</dc:creator>\n<dc:creator>Spaeth-;Rublee B</dc:creator>\n<dc:creator>Pincus
|
877
|
+
H.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
|
878
|
+
The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
879
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
880
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2319350\"><b>Quality
|
881
|
+
Metrics for Physical and Behavioral Health Care Integration</b></A><br />Goldman
|
882
|
+
ML Spaeth-Rublee B, Pincus H.<br /><i>JAMA The Journal of the American Medical
|
883
|
+
Association, Vol. , No. (2015) pp. - </i><br /><span class=\"paragraphSection\">This
|
884
|
+
Viewpoint discusses developing quality metrics in behavioral and general health
|
885
|
+
care to encourage more cost-effective care and improve the status quo.</span></p>]]></content:encoded>\r\n</item>\n<item
|
886
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2338303\">\n<title>Middle
|
887
|
+
East Respiratory Syndrome: A Global Health Challenge</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2338303</link>\r\n<description><span
|
888
|
+
class=\"paragraphSection\">This Viewpoint discusses the importance of a
|
889
|
+
well-trained and well-prepared health workforce in controlling outbreaks such
|
890
|
+
as Middle East respiratory syndrome.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2338303</dc:identifier>\r\n<dc:creator>Gostin
|
891
|
+
LO</dc:creator>\n<dc:creator>Lucey D.</dc:creator>\n<dc:publisher>American
|
892
|
+
Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
|
893
|
+
of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
894
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
895
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2338303\"><b>Middle
|
896
|
+
East Respiratory Syndrome: A Global Health Challenge</b></A><br />Gostin LO
|
897
|
+
Lucey D.<br /><i>JAMA The Journal of the American Medical Association, Vol.
|
898
|
+
, No. (2015) pp. - </i><br /><span class=\"paragraphSection\">This
|
899
|
+
Viewpoint discusses the importance of a well-trained and well-prepared health
|
900
|
+
workforce in controlling outbreaks such as Middle East respiratory syndrome.</span></p>]]></content:encoded>\r\n</item>\n<item
|
901
|
+
rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429718\">\n<title>The
|
902
|
+
“Good Person” Sign</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429718</link>\r\n<description><span
|
903
|
+
class=\"paragraphSection\">When I started medical school, I received a
|
904
|
+
lot of (mostly unsolicited) advice on various topics, ranging from specialty
|
905
|
+
choice to the importance of keeping work-life balance to how to befriend nurses
|
906
|
+
in order to get things done. I would listen passively while friends and family
|
907
|
+
blathered on about how comfortable their subspecialists’ lifestyles
|
908
|
+
were. One recurring theme that I actively paid attention to was how often
|
909
|
+
people advised me to avoid becoming “one of those” doctors who
|
910
|
+
distanced themselves from their patients. I didn’t quite understand
|
911
|
+
why some people could ever view physicians to be uncaring, cold, and callous,
|
912
|
+
and why physicians allowed themselves to be perceived as such. Medicine is
|
913
|
+
still the noblest of professions, and one would expect altruism as a baseline
|
914
|
+
for all who go into the field. Personally, I was able to hold on tightly to
|
915
|
+
my humanity and positive attitude throughout the preclinical years of medical
|
916
|
+
school without issue. I even received high marks for compassion and empathy
|
917
|
+
in our “doctoring” courses. At that point in my training I continued
|
918
|
+
to feel as though I were above falling victim to the fate of the heartless
|
919
|
+
physician. So why, I wondered in my short, unwrinkled, and as yet unblemished
|
920
|
+
white coat, were some physicians so detached from their patients' Once
|
921
|
+
the clinical years started, I quickly discovered the answer.</span></description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429718</dc:identifier>\r\n<dc:creator>Dempsey
|
922
|
+
TM.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
|
923
|
+
The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
|
924
|
+
25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
|
925
|
+
href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429718\"><b>The
|
926
|
+
“Good Person” Sign</b></A><br />Dempsey TM. <br /><i>JAMA The
|
927
|
+
Journal of the American Medical Association, Vol. , No. (2015) pp. - </i><br
|
928
|
+
/><span class=\"paragraphSection\">When I started medical school, I
|
929
|
+
received a lot of (mostly unsolicited) advice on various topics, ranging from
|
930
|
+
specialty choice to the importance of keeping work-life balance to how to
|
931
|
+
befriend nurses in order to get things done. I would listen passively while
|
932
|
+
friends and family blathered on about how comfortable their subspecialists’
|
933
|
+
lifestyles were. One recurring theme that I actively paid attention to was
|
934
|
+
how often people advised me to avoid becoming “one of those” doctors
|
935
|
+
who distanced themselves from their patients. I didn’t quite understand
|
936
|
+
why some people could ever view physicians to be uncaring, cold, and callous,
|
937
|
+
and why physicians allowed themselves to be perceived as such. Medicine is
|
938
|
+
still the noblest of professions, and one would expect altruism as a baseline
|
939
|
+
for all who go into the field. Personally, I was able to hold on tightly to
|
940
|
+
my humanity and positive attitude throughout the preclinical years of medical
|
941
|
+
school without issue. I even received high marks for compassion and empathy
|
942
|
+
in our “doctoring” courses. At that point in my training I continued
|
943
|
+
to feel as though I were above falling victim to the fate of the heartless
|
944
|
+
physician. So why, I wondered in my short, unwrinkled, and as yet unblemished
|
945
|
+
white coat, were some physicians so detached from their patients' Once
|
946
|
+
the clinical years started, I quickly discovered the answer.</span></p>]]></content:encoded>\r\n</item>\n\r\n\t\r\n
|
947
|
+
\ <rdf:Description rdf:ID=\"manifest\">\r\n <mn:channels>\r\n <rdf:Seq>\r\n
|
948
|
+
\ <rdf:li rdf:resource=\"http://www.journaltocs.hw.ac.uk/api/journals\"
|
949
|
+
/>\r\n </rdf:Seq>\r\n </mn:channels>\r\n </rdf:Description>\r\n\r\n</rdf:RDF>"
|
950
|
+
http_version:
|
951
|
+
recorded_at: Thu, 03 Sep 2015 20:09:20 GMT
|
952
|
+
recorded_with: VCR 2.9.3
|